News Immatics Announces Full Year 2024 Financial Results and Business Update by Trophic 27 March, 2025
News Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME by Trophic 18 November, 2024
News Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME by Trophic 08 November, 2024
